Use of exogenous gonadotropins in anovulatory women: a technical bulletin

Fertility and Sterility

Volumn 90, Issue 5 SUPPL., 2008, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN DERIVATIVE; LEUPRORELIN; METFORMIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

AMENORRHEA; ARTICLE; COMBINATION CHEMOTHERAPY; CORPUS LUTEUM; DRUG EFFICACY; DRUG SAFETY; FEMALE INFERTILITY; HUMAN; HYPOGONADOTROPIC AMENORRHEA; OOCYTE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; SEXUAL INTERCOURSE;

AMENORRHEA; ANOVULATION; COITUS; FEMALE; GONADOTROPINS; HEALTH PLANNING GUIDELINES; HUMANS; HYPOGONADISM; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PRECONCEPTION CARE; PREGNANCY; PROFESSIONAL PRACTICE; TIME FACTORS;

EID: 55549137431     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.003     Document Type: Article

References (59)

1. Huirne J.A., Lambalk C.B., van Loenen A.C., Schats R., Hompes P.G., Fauser B.C., et al. Contemporary pharmacological manipulation in assisted reproduction. Drugs 64 (2004) 297-322
2. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 86 Suppl 5 (2006) S148-S155
3. Reindollar R.H., Novak M., Tho S.P., and McDonough P.G. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 155 (1986) 531-543
4. Biller B.M., Luciano A., Crosignani P.G., Molitch M., Olive D., Rebar R., et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med 44 Suppl 12 (1999) 1075-1084
5. Filicori M. Clinical review 81: gonadotropin-releasing hormone analogs in ovulation induction: current status and perspectives. J Clin Endocrinol Metab 81 (1996) 2413-2416
6. Burgues S., and Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod 16 (2001) 2525-2532
7. Cristello F., Cela V., Artini P.G., and Genazzani A.R. Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome. Gynecol Endocrinol 21 (2005) 340-352
8. Ratts V.S., Pauls R.N., Pinto A.B., Kraja A., Williams D.B., and Odem R.R. Risk of multiple gestation after ovulation induction in polycystic ovary syndrome. J Reprod Med 52 (2007) 896-900
9. Bayram N., van Wely M., and van Der Veen F. Recombinant FSH versus urinary gonadotropins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev (2001) (2):CD002121
10. The Practice Committee of the American Society for Reproductive Medicine. Gonadotropin preparations: past, present, and future perspectives. Fertil Steril 90 Suppl 3 (2008) S13-20
11. Baruffi R.L., Contart P., Mauri A.L., Petersen C., Felipe V., Garbellini E., et al. A uterine ultrasonographic scoring system as a method for the prognosis of embryo implantation. J Assist Reprod Genet 19 (2002) 99-102
12. Filicori M., Cognigni G.E., Pocognoli P., Tabarelli C., Ferlini F., Perri T., et al. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril 80 (2003) 390-397
13. Filicori M., Cognigni G.E., Samara A., Melappioni S., Perri T., Cantelli B., et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 8 (2002) 543-557
14. Shoham Z., Balen A., Patel A., and Jacobs H.S. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patitents. Fertil Steril 56 (1991) 1048-1053
15. Couzinet B., Lestrat N., Brailly S., Forest M., and Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 66 (1988) 552-556
16. European Recombinant Human LH Study Group. Recombinant human luteinising hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 83 (1998) 1507-1514
17. Filicori M., Cognigni G.E., Taraborrelli S., Spettoli D., Ciampaglia W., and de Fatis C.T. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril 72 (1999) 1118-1120
18. Kousta E., White D.M., Piazzi A., Loumaye E., and Franks S. Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome. Hum Reprod 11 (1996) 70-71
19. Filicori M., Cognigni G.E., Pocognoli P., Ciampaglia W., and Bernardi S. Current concepts and novel applications of LH activity in ovarian stimulation. Trends Endocrinol Metab 14 (2003) 267-273
20. Nugent D., Vandekerckhove P., Hughes E., Arnot M., and Lilford R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev (2000) (4):CD000410
21. Yarali H., Bukulmez O., and Gurgan T. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertil Steril 72 (1999) 276-281
22. Van Der Meer M., Hompes P.G., De Boer J.A., Schats R., and Schoemaker J. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 423-426
23. White D.M., Polson D.W., Kiddy D., Sagle P., Watson H., Gilling-Smith C., et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 81 (1996) 3821-3824
24. Fauser B.C., and Van Heusden A.M. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18 (1997) 71-106
25. Calaf Alsina J., Ruiz Balda J.A., Romeu Sarrió A., Caballero Fernández V., Cano Trigo I., Gómez Parga J.L., et al. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. BJOG 110 (2003) 1072-1077
26. Christin-Maitre S., and Hugues J.N. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 18 (2003) 1626-1631
27. Andoh K., Mizunuma H., Liu X., Kamijo T., Yamada K., and Ibuki Y. A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome. Fertil Steril 70 (1998) 840-846
28. Balasch J., Fabregues F., Creus M., Puerto B., Penarrubia J., and Vanrell J.A. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. Hum Reprod 16 (2001) 652-656
29. van Santbrink E.J., and Fauser B.C. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab 82 (1997) 3597-3602
30. Chang P., Kenley S., Burns T., Denton Currie K., DeVane G., et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 76 (2001) 67-74
31. European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 86 (2001) 2607-2618
32. Balasch J., Tur R., Creus M., Buxaderas R., Fabregues F., Ballesca J.L., et al. Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecol Endocrinol 8 (1994) 7-12
33. Lewit N., Kol S., Manor D., and Itskovitz-Eldor J. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-contol study. Hum Reprod 11 (1996) 1399-1402
34. Mulders A.G.M.G.J., Laven J.S.E., Eijkemans M.J.C., and Fauser B.C.J.M. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update 9 (2003) 429-449
35. Fluker M.R., Urman B., Mackinnon M., Barrow S.R., Pride S.M., and Ho Yuen B. Exogenous gonadotrophin therapy in World Health Organization groups I and II ovulatory disorders. Obstet Gynecol 83 (1994) 189-196
36. Nugent D., Vandekerckhove P., Hughes E., Arnot M., and Lilford R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev (2000) (3):CD000410
37. Ron-el R., Soffer Y., Langer R., Herman A., Weintraub Z., and Caspi E. Low multiple pregnancy rate in combined clomiphene citrate-human menopausal gonadotrophin treatment for ovulation induction or enhancement. Hum Reprod 4 (1989) 495-500
38. Kemmann E., and Jones J.R. Sequential clomiphene citrate-menotropin therapy for induction or enhancement of ovulation. Fertil Steril 39 (1983) 772-779
39. Legro R.S., Barnhart H.X., Schlaff W.D., Carr B.R., Diamond M.P., Carson S.A., et al., Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007) 551-566
40. Palomba S., Orio Jr. F., Falbo A., Manguso F., Russo T., Cascella T., et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 (2005) 4068-4074
41. De Leo V., la Marca A., Ditto A., Morgante G., and Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72 (1999) 282-285
42. van Santbrink E.J., Hohmann F.P., Eijkemans M.J., Laven J.S., and Fauser B.C. Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment. Eur J Endocrinol 152 (2005) 611-617
43. Weerakiet S., Lertvikool S., Tingthanatikul Y., Wansumrith S., Leelaphiwat S., and Jultanmas R. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling. Gynecol Endocrinol 2 (2007) 1-6
44. Farquhar C., Lilford R.J., Marjoribanks J., and Vandekerckhove P. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev (2007) (3):CD001122
45. Smitz J., Erard P., Camus M., Devroey P., Tournaye H., Wisanto A., et al. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 7 (1992) 1225-1229
46. Beckers N.G., Macklon N.S., Eijkemans M.J., Ludwig M., Felberbaum R.E., Diedrich K., et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88 (2003) 4186-4192
47. Tavaniotou A., and Devroey P. Luteal hormone profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online 13 (2006) 326-330
48. Quintero R.B., Urban R., Lathi R.B., Westphal L.M., and Dahan M.H. A comparison of letrozole to gonadotropins for ovulation induction, in subjects who failed to conceive with clomiphene citrate. Fertil Steril 88 (2007) 879-885
49. Casper R.F. Aromatase inhibitors in ovarian stimulation. J Steroid Biochem Mol Biol 106 (2007) 71-75
50. Badawy A., Metwally M., and Fawzy M. Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility. Reprod Biomed Online 14 (2007) 559-562
51. Forman R., Gill S., Moretti M., Tulandi T., Koren G., and Casper R. Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynaecol Can 29 (2007) 668-671
52. Tulandi T., Martin J., Al-Fadhli R., Kabli N., Forman R., Hitkari J., et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85 (2006) 1761-1765
53. Shibahara H., Kikuchi K., Hirano Y., Suzuki T., Takamizawa S., and Suzuki M. Increase of multiple pregnancies caused by ovulation induction with gonadotropin in combination with metformin in infertile women with polycystic ovary syndrome. Fertil Steril 87 (2007) 1487-1490
54. Ratts V.S., Pauls R.N., Pinto A.B., Kraja A., Williams D.B., and Odem R.R. Risk of multiple gestation after ovulation induction in polycystic ovary syndrome. J Reprod Med 52 (2007) 896-900
55. Stone J., Belogolovkin V., Matho A., Berkowitz R.L., Moshier E., and Eddleman K. Evolving trends in 2000 cases of multifetal pregnancy reduction: a single-center experience. Am J Obstet Gynecol 197 (2007) 394
56. Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 86 Suppl 5 (2006) S178-S183
57. Brinton L.A., Moghissi K.S., Scoccia B., Westhoff C.L., and Lamb E.J. Ovulation induction and cancer risk. Fertil Steril 83 (2005) 261-274
58. Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J.E., et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103 (2004) 1194-1203
59. Glud E., Kjaer S.K., Troisi R., and Brinton L.A. Fertility drugs and ovarian cancer. Epidemiol Rev 20 (1998) 237-257